Dhruba J Bharali Selected Research

Dhruba J Bharali Research Topics

Disease

24	Neoplasms (Cancer) 02/2022 - 09/2007
5	Breast Neoplasms (Breast Cancer) 02/2018 - 12/2013
4	Glioblastoma (Glioblastoma Multiforme) 02/2023 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2023 - 06/2013
3	Necrosis 01/2020 - 08/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 02/2014
2	Inflammation (Inflammations) 02/2022 - 01/2018
2	Carcinoma (Carcinomatosis) 02/2022 - 03/2010
1	Hypercholesterolemia 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Amyloid Plaque 07/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Anemia 01/2020
1	Neoplasm Metastasis (Metastasis) 12/2019
1	Pathologic Neovascularization 12/2019
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2019
1	Dermatitis 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2017
1	Glioma (Gliomas) 01/2017
1	Hypothyroidism 01/2017
1	Fibrosis (Cirrhosis) 09/2015
1	Melanoma (Melanoma, Malignant) 11/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2012
1	Macular Degeneration (Age-Related Maculopathy) 01/2012

Drug/Important Bio-Agent (IBA)

10	tetraiodothyroacetic acid (TA(4))IBA 05/2023 - 03/2010
6	IntegrinsIBA 01/2020 - 06/2013
5	ChitosanIBA 01/2018 - 01/2012
5	PolyphenolsIBA 01/2018 - 03/2009
5	TeaIBA 01/2018 - 03/2009
4	Thyroid HormonesIBA 01/2017 - 03/2010
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2023 - 12/2019
3	TriazolesIBA 02/2023 - 12/2019
3	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 02/2017
3	Cell Surface ReceptorsIBA 01/2017 - 03/2010
3	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2017 - 03/2010
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 11/2014 - 03/2009
3	Dendrimers (Dendrons)IBA 07/2011 - 01/2009
2	NF-kappa B (NF-kB)IBA 02/2022 - 06/2019
2	CytokinesIBA 01/2020 - 01/2018
2	taribavirin (viramidine)IBA 01/2020 - 02/2018
2	nano-diamino-tetracIBA 02/2017 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2017 - 09/2015
2	Hormones (Hormone)IBA 08/2015 - 03/2010
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2014 - 02/2014
2	PhytochemicalsIBA 02/2014 - 03/2009
2	Proteins (Proteins, Gene)FDA Link 02/2014 - 06/2013
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2022
1	AntioxidantsIBA 02/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	EnzymesIBA 01/2022
1	Proprotein Convertase 9IBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Ellagic AcidIBA 01/2021
1	AluminumIBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 07/2020
1	cresyl violetIBA 07/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2020
1	SilverIBA 07/2020
1	Neuroprotective AgentsIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	3- (3- (3- (4,5- dihydroimidazol- 2- ylamino)propyloxylisoxazol- 5- yl)carbonylamino)- 2- (phenylsulfonylamino)propionic acidIBA 01/2020
1	NucleosidesIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Ribavirin (Virazole)FDA LinkGeneric 01/2020
1	parthenolideIBA 06/2019
1	Lipid NanoparticlesIBA 02/2018
1	Fluorouracil (Carac)FDA LinkGeneric 02/2018
1	Imiquimod (Aldara)FDA LinkGeneric 01/2018
1	ChemokinesIBA 01/2018
1	Caspase 14IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 06/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017
1	LuciferasesIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	CollagenIBA 09/2015
1	ParaffinIBA 09/2015
1	Estrogens (Estrogen)FDA Link 08/2015
1	Estrogen ReceptorsIBA 08/2015
1	Toremifene (Fareston)FDA Link 08/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 02/2014
1	CaspasesIBA 02/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2014
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 12/2013
1	Antineoplastic Agents (Antineoplastics)IBA 12/2013
1	Thrombospondin 1IBA 06/2013
1	Hemoglobins (Hemoglobin)IBA 06/2013
1	Peptides (Polypeptides)IBA 01/2012

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2007
5	Drug Therapy (Chemotherapy) 01/2020 - 07/2011
3	Quantum Dots (Quantum Dot) 07/2011 - 01/2009
2	Chemoprevention 01/2015 - 03/2009
1	Aftercare (After-Treatment) 01/2017
1	Oral Administration 02/2014